Mechanisms and control of pathologic bone loss in periodontitis.
Bartold
P Mark
PM
Cantley
Melissa D
MD
Haynes
David R
DR
D016301:Alveolar Bone Loss / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology*; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D018836:Inflammation Mediators / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D016173:Macrophage Colony-Stimulating Factor / Q000378:metabolism; D010010:Osteoclasts / Q000502:physiology; D053244:Osteoprotegerin / Q000378:metabolism; D010518:Periodontitis / Q000150:complications*; D053245:RANK Ligand / Q000378:metabolism; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000378:metabolism; D019014:fas Receptor / Q000378:metabolism
D016207:Cytokines; D018836:Inflammation Mediators; D047908:Intracellular Signaling Peptides and Proteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D019014:fas Receptor; D016173:Macrophage Colony-Stimulating Factor